Theobromine Oral Pouch Composition for Fast Sustained Release
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing oral products containing theobromine do not provide a sufficient, fast, and sustained stimulating effect, and are not easily consumable, lacking sensory attractiveness and ease of use.
Innovation Solution
An oral product comprising a pouch with a composition containing theobromine and cocoa bean nibs as a carrier, which releases theobromine upon contact with mucosa without chewing, allowing for a fast and sustained release into the bloodstream.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Quantity of substance
If chocolate or cocoa products are used to provide theobromine, then theobromine intake is achieved, but excessive intake can cause adverse effects such as restlessness, increased heart rate, and insomnia
Solution Approach 1:
The patent changes the concentration parameter of theobromine in the oral composition to a specific range (0.1-10% w/w) that is sufficient to provide therapeutic effects while avoiding excessive intake that causes adverse effects. This parameter optimization resolves the contradiction between achieving adequate theobromine intake and avoiding harmful side effects.
2Reliability
If theobromine is provided in oral compositions, then cardiovascular and respiratory benefits are achieved, but the composition must be stable and safe for consumption
Solution Approach 1:
The patent specifies precise parameter ranges for theobromine concentration (0.1-10% w/w) and pH value (3.0-7.0) to ensure the composition is stable, safe for consumption, and effective for cardiovascular and respiratory benefits. These parameter optimizations simultaneously achieve reliability of benefits and safety of composition.
3Reliability
If high concentrations of theobromine are used, then therapeutic effects are enhanced, but the risk of adverse effects increases
Solution Approach 1:
The patent identifies and optimizes the optimal concentration range of theobromine (0.1-10% w/w) that maximizes therapeutic effects while minimizing the risk of adverse effects. This parameter optimization resolves the contradiction between enhancing therapeutic effects and reducing adverse effect risk.
Data Source
AI summary
The invention relates to an oral product for delivery of at least one active ingredient comprising or consisting of - a pouch defining a cavity and - a composition comprising the at least one active ingredient and a carrier selected from the group consisting of, cocoa bean, in particular cocoa bean nibs or cocoa bean powder, coffee bean, cellulose, plant fibres, polysaccharides, oligosaccharides, polyols, and mixtures of at least two of the afore-said carriers, wherein the composition is within the cavity of the pouch and the at least one active ingredient is theobromine. The invention further relates to a method for producing an oral product.